Quantitative assessment of oligomeric amyloid β peptide binding to α7 nicotinic receptor.

Erika CeconJulie DamMarine LukaClément GautierAnne-Marie CholletPhilippe DelagrangeLaurence DanoberRalf Jockers

Published in: British journal of pharmacology (2019)

This article is part of a themed section on Therapeutics for Dementia and Alzheimer's Disease: New Directions for Precision Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.18/issuetoc.

Keyphrases

mild cognitive impairment
cognitive decline
small molecule
cognitive impairment
benign prostatic hyperplasia
lower urinary tract symptoms